UBS cuts target for Healthcare Realty Trust stock to USD 18.00
Published on 10/20/2026 at 19:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSTarget and reporting date
- UBS revised its Healthcare Realty Trust target on October 13, 2026.
- Third-quarter results are scheduled for October 29, 2026.
- Healthcare Realty Trust stock costs EUR 15.75 at Lang & Schwarz on October 20, 2026 at 7:15 p.m. CEST.
- Healthcare Realty reported USD 278.58 million in second-quarter revenue and a USD 0.13 loss per share.
Healthcare Realty Trust (ISIN US42226K1051) faces a lower UBS valuation view ahead of its next report. On October 13, 2026, UBS Group cut its target from USD 21.00 to USD 18.00 and kept a Neutral rating, as MarketBeat reported. The stock was trading at EUR 15.75 at Lang & Schwarz on October 20, 2026 at 7:15 p.m. CEST.
UBS resets the valuation bar
The UBS change puts a USD 18.00 target alongside a Neutral rating after the previous USD 21.00 objective. MarketBeat said the note implied 4.40 percent upside from the prior US market level, while its broader analyst tally showed four Buy ratings and seven Hold ratings on October 13, 2026.
The revised target is not the only dated reference for investors. Healthcare Realty's second-quarter revenue was USD 278.58 million, compared with a USD 271.60 million consensus estimate, but the company posted a USD 0.13 loss per share against an expected USD 0.40 profit, according to MarketBeat on October 13, 2026. Revenue was 5.30 percent below the year-earlier period.
Results arrive October 29
Healthcare Realty scheduled its third-quarter 2026 results for October 29, 2026, after the market closes. The company also scheduled a conference call for October 30, 2026, at 9:00 a.m. Eastern Time, in a release dated October 5, 2026, published by Healthcare Realty.
How does HR compare?
Healthcare Realty's October 20, 2026 market capitalization was USD 6.2 billion, with a trailing price-to-earnings ratio of minus 67.54. Ventas stood at USD 44.2 billion in market capitalization with a 159.57 ratio, while Healthpeak Properties stood at USD 12.9 billion and a 53.61 ratio on the same date.
Stock position and valuation
Healthcare Realty's one-year range was USD 16.31 to USD 22.04 as reported on October 13, 2026. Its October 20, 2026 dividend yield was 5.00 percent, and the company had set 2026 earnings-per-share guidance at USD 1.62 to USD 1.66, according to the same MarketBeat report.
Healthcare Realty stock after hours
At Lang & Schwarz, Healthcare Realty Trust stock was trading at EUR 15.75 on October 20, 2026 at 7:15 p.m. CEST. The price gives investors a current euro reference ahead of the October 29 results date.
The further course of trading is shown by the continuously updated real-time quote of Healthcare Realty Trust stock.
Healthcare Realty Trust market facts
- Company: Healthcare Realty Trust Incorporated
- ISIN: US42226K1051
- Ticker: HR
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 20, 2026, 7:15 p.m. CEST): EUR 15.75
- Market capitalization: USD 6.2 billion (as of October 20, 2026)
- 52-week range: USD 16.31-22.04 (as of October 13, 2026)
- Sector / Industry: Real Estate / Healthcare Facilities REIT
Market context: Market report S&P 500.
